What should the psych nurse practitioner do for an 81-year-old female with worsening depression, a GDS score of 8, and recently increased levothyroxine, who is currently on Lexapro (escitalopram) 10 mg a day?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Worsening Depression in an Elderly Patient with Hypothyroidism

The psych nurse practitioner should wait to observe the effects of the recent levothyroxine dose increase for at least 2-3 more weeks before considering any changes to the patient's antidepressant regimen.

Assessment of Current Situation

The 81-year-old female patient presents with:

  • Stable on escitalopram (Lexapro) 10 mg daily for 3 years
  • Subjective complaint of worsening depression
  • GDS score of 8 (unchanged from previous month)
  • Elevated TSH of 8
  • Recent levothyroxine dose increase 3 days ago

Rationale for Waiting Approach

  1. Hypothyroidism and Depression Connection

    • Hypothyroidism is a known secondary cause of depressive symptoms 1
    • The patient's elevated TSH (8) indicates suboptimal thyroid function, which may be contributing to her depressive symptoms
    • Recent research shows that increasing levothyroxine dose can improve depressive mood in older adults with hypothyroidism 2
  2. Timing Considerations

    • The levothyroxine dose was increased only 3 days ago
    • Thyroid hormone adjustments typically require 4-6 weeks to reach full effect
    • Premature medication changes could lead to overtreatment
  3. Stability Assessment

    • The GDS score of 8 is unchanged from the previous month, indicating stable rather than worsening symptoms despite the patient's subjective complaint
    • A GDS score of 8 suggests mild-moderate depression (GDS-SF score ≥ 5 necessitates follow-up) 1

Monitoring Plan

  • Schedule a follow-up appointment in 2-3 weeks to reassess depressive symptoms
  • Administer the GDS again at follow-up to objectively measure any changes
  • Monitor for potential hyperthyroid symptoms that might occur with the increased levothyroxine dose
  • Evaluate for clinical improvement in depressive symptoms in response to thyroid optimization

Next Steps Based on Follow-up Assessment

If no improvement after 4-6 weeks of optimized thyroid function:

  • Consider increasing escitalopram dose from 10mg to 15-20mg daily
  • The American College of Physicians recommends clinical monitoring within 1-2 weeks after any antidepressant dose change 3
  • Monitor closely for side effects, particularly in this elderly patient who may be more sensitive to medication changes

Important Considerations

  • Age-related factors: At 81 years old, the patient is at higher risk for medication side effects and requires careful monitoring with any medication changes 3
  • Drug interactions: Monitor for potential interactions between levothyroxine and escitalopram
  • Avoid premature medication changes: Making multiple medication changes simultaneously can confuse the clinical picture and make it difficult to determine which intervention is effective or causing side effects
  • Discontinuation symptoms: If changes to escitalopram are eventually needed, be aware of potential discontinuation symptoms which can be more pronounced in elderly patients 4

Caution

  • While waiting to observe the effects of thyroid medication adjustment, continue to monitor for any signs of suicidal ideation, as this would warrant immediate intervention regardless of other factors
  • If the patient shows any clinical deterioration during the waiting period, earlier reassessment would be indicated

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Monitoring Antidepressant Therapy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.